[1]
Fuiani, A. 2021. The Utility of Delta-9-Tetrahydrocannibinol Therapy in a Multiple Sclerosis Patient with a Neoplastic Brain Lesion . European Journal of Case Reports in Internal Medicine. 8, 5 (May 2021). DOI:https://doi.org/10.12890/2021_002188.